What is JAZZ's five-year median P/E?

18.0x. Half of JAZZ's weekly readings since November 2023 were higher and half were lower. This page has 765 weekly readings, from Feb 27, 2012 to Oct 19, 2026.

Does a low historical rank mean a stock is a buy?

No. The rank compares JAZZ only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.

Jazz Pharmaceuticals PLC (JAZZ) valuation history

Health Care

$214.00

Latest weekly close · Market cap $14.9B

Below its usual range

As of Oct 24, 2026

JAZZ's P/E of 14.6x is lower than 88% of its weekly readings since November 2023.

Weekly P/E since November 2023

P/E each weekMiddle half of its readingsMedian 18.0×

Median: 18.0×
Low to high: 11.6×–153.8×
Versus median: -19%
History starts: November 2023

P/E

12thpercentile

of its weekly readings since November 2023

Below its usual range

Growth, last 12 months vs the year before

Revenue: +13%accelerating
EPS: n/a

Price vs revenue and EPS, indexed to 100

Each line starts at 100 at its first positive reading over the last five years. Revenue and EPS change at fiscal quarter ends.

PriceRevenue, last 12 monthsEPS, last 12 months100 = first reading

P/E at each year-end

The last weekly reading of each year, and its percentile against the five years before it.

JAZZ P/E at each year-end
Year-end	P/E	5-year percentile
Dec 29, 2025	n/a	Too little history
Dec 30, 2024	17.0×	13
Dec 25, 2023	143.0×	100
Dec 26, 2022	n/a	Too little history
Dec 27, 2021	n/a	Too little history
Dec 28, 2020	52.1×	95
Dec 30, 2019	14.0×	6
Dec 31, 2018	15.2×	1
Dec 25, 2017	22.2×	30
Dec 26, 2016	19.1×	26

Health Care peers on P/E

Each percentile compares a stock with its own last five years.

Compare JAZZ with peers

Health Care peers of JAZZ on P/E
Stock	P/E	Versus its own history	5-year percentile
AXSMAxsome Therapeutics Inc	n/a	Not ranked	n/a, not ranked
BMYBristol Myers Squibb	13.9×	Below its usual range	15
CORTCorcept Therapeutics Inc	204.4×	Historically high	92
ELANElanco Animal Health Inc	n/a	Not ranked	n/a, not ranked
JNJJohnson & Johnson	40.6×	Historically high	100

Appears in

Sector: Health Care
Screens: Stocks with Low P/E Ratios and Steady Revenue Growth
Stocks Below Their 5-Year Median P/E
Stocks Near Their Lowest P/E Ratios in 5 Years

Screen Health Care stocks the same way

Research on JAZZ

No articles about JAZZ yet. How valuation percentiles work

Loading peers and related research…

About this history

What is JAZZ's current P/E?: JAZZ's P/E of 14.6x is lower than 88% of its weekly readings since November 2023.
What is JAZZ's five-year median P/E?: 18.0x. Half of JAZZ's weekly readings since November 2023 were higher and half were lower. This page has 765 weekly readings, from Feb 27, 2012 to Oct 19, 2026.
Does a low historical rank mean a stock is a buy?: No. The rank compares JAZZ only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.